Aberrant Stress Response Associated with Severe Hypoglycemia in a Transgenic Mouse Model of Alzheimer's Disease
- 1 January 1999
- journal article
- Published by Springer Nature in Journal of Molecular Neuroscience
- Vol. 13 (1-2) , 159-166
Abstract
Patients with Alzheimer’s disease (AD) exhibit alterations in glucose metabolism and dysregulation of the stress-responsive hypothalamic-pituitary-adrenal (HPA) neuroendocrine system. The mechanisms responsible for these alterations and their possible contributions to the neurodegenerative process in AD are unknown. We now report that transgenic mice expressing a mutant form of human amyloid precursor protein (APP) that causes inherited early-onset AD exhibit increased sensitivity to physiological stressors, which is associated with aberrancies in HPA function and regulation of blood glucose levels. Specifically, APP mutant mice exhibit severe hypoglycemia and death following food restriction, and sustained elevations of plasma glucocorticoid levels and hypoglycemia following restraint stress. The alterations in HPA function and glucose regulation were evident in relatively young mice prior to overt deposition of amyloid β-peptide (Aβ). However, diffuse accumulations of Aβ were present in the hypothalamus of older mice, suggesting a role for soluble forms of Aβ in dysregulation of HPA function. Our data demonstrate disturbances in neuroendocrine function in APP mutant mice similar to those seen in AD patients. These impairments in stress response, glucocorticoid signaling, and regulation of blood glucose should be considered in interpretations of data from past and future studies of APP mutant mice.Keywords
This publication has 23 references indexed in Scilit:
- Protein modification by the lipid peroxidation product 4‐hydroxynonenal in the spinal cords of amyotrophic lateral sclerosis patientsAnnals of Neurology, 1998
- Comparison of β-protein/A4 deposits and Alz-50-stained cytoskeletal changes in the hypothalamus and adjoining areas of Alzheimer's disease patients: amorphic plaques and cytoskeletal changes occur independentlyActa Neuropathologica, 1998
- Detrimental effects of chronic hypothalamic—pituitary—adrenal axis activationMolecular Neurobiology, 1998
- Diffusible, nonfibrillar ligands derived from Aβ 1–42 are potent central nervous system neurotoxinsProceedings of the National Academy of Sciences of the United States of America, 1998
- 4‐Hydroxynonenal‐Derived Advanced Lipid Peroxidation End Products Are Increased in Alzheimer's DiseaseJournal of Neurochemistry, 1997
- Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic MiceScience, 1996
- Metyrapone, an Inhibitor of Glucocorticoid Production, Reduces Brain Injury Induced by Focal and Global Ischemia and SeizuresJournal of Cerebral Blood Flow & Metabolism, 1996
- Hypothalamic-pituitary-adrenal system function in patients with alzheimer's diseaseNeurobiology of Aging, 1995
- The Function of the Hypothalamic–Pituitary–Adrenal Axis in Alzheimer's DiseaseThe British Journal of Psychiatry, 1994
- Glucose deprivation elicits neurofibrillary tangle-like antigenic changes in hippocampal neurons: Prevention by NGF and bFGFExperimental Neurology, 1992